INTRODUCTION C
hagas' disease, caused by the transmission of Trypanosoma crud, is one of the greatest public health problems faced by many Latin American countries, and in regions ranging from the southern United States to Argentina (53). The disease is characterized by three phases: acute, latent and chronic (l,43) . The most important visceral involvement is that of the heart. During the acute phase the degree of myocardial involvement varies from slight asymptomatic or oligosymptomatic to serious, even fatal, forms. These serious forms are not frequent, making up just 3.5% of the cases. During the initial stages of the chronic phase the patient may be asymptomatic or show some symptoms related with heartbeat disturbance; during intermediate stages, clinical manifestation persists or intensifies, heart enlargement may be detected, varying from slight to moderate; in the final stage heart enlargement is more pronounced plus serious congestive cardiac failure, thromboembolic phenomenon and serious arrhythmia. Sudden death is a constant risk at any stage of the disease.
The latent phase is the intermediate period separating the acute and chronic ones, and is usually long lasting (from 10 to 20 years). Little is known regarding the clinical pathological manifestations.
The pathology reflects the importance of cardiac involvement in Chagas' disease (20) . During the acute phase, the heart is globous and flaccid; regions of myocytic necrosis and myocellular degeneration can be observed microscopically with intense infiltrated lymphomononuclear inflammation associated with exudative phenomenon and myofiber parasitism. During the chronic phase, cardiopathy is polymorph, with varying degrees of hypertrophy and dilation. Apical aneurysm may or may not be present. A focused or diffuse infiltrated lymphomononuclear inflammation may be microscopically observed, plus regions of myocytic necrosis and degeneration of myocardial cells, interstitial fibrosis of varying degrees and rare fibers with intracellular parasites. The Chronic Chagas' Myocarditis Pathogenesis is, however, not completely understood. Several different types of treatment have been proposed.
DIRECT TISSUE lESION BY TRYPANOSOMA CRUZI
Lesions may be caused by continued invasion of the myocardium, by localized liberation of toxins, or both. Insignificant parasitemia levels and the occasional finding of parasitic pseudocysts are arguments against the theory that myocardial lesions are directly correlated to the presence of the parasites. However a possible relationship between the presence of the T. cruzi immunogens and the intensity of inflammatory infiltrate has been observed in autopsied chronic Chagas' patients, suggesting therefore that the parasite has a role in perpetuating chronic myocarditis (15).
NEUROGENIC THEORY
Chronic myocardiopathy caused by Chagas' disease can be considered as cardioneuropathy due to the destruction of the heart's parasympathetic ganglionic cells (20, 29) . Histological studies show an accentuated reduction in the number of parasympathetic cardiac neurons in proportion to the alterations in heart pathologies (20,29). These observations have been contested by researchers who have noticed an absence of neuronal lesion at the onset of the disease, and no relationship between the neuronal count and the disease's progress. Myocardial lesions and discrete ventricular dilation preceded parasympathetic functional heart abnormalities in Chagas' patients. However, results of recent functional studies have confirmed the occurrence of abnormalities of the regulating neural heart mechanisms in chronic Chagas' patients without cardiac insufficiency.
ANTIMYOCARDIAl IMMUNOLOGICAL REACTIONS
The action of self immune mechanisms has been held to be the main cause of chronic Chagas' myocarditis (1,18,30,43).
Setting up an experimental model which could provide evidence in favor of this theory to allow reliable immunological handling would be extremely important.
We have shown in a recent study that lab mice when chronically infected by T. cruzi were capable of rejecting syngenical hearts of new-born ear-transplanted animals (32). Transplanted syngenical heart rejection happened quicker than when compared to an allogenic situation. These observations were in complete contrast to normal or T. cruzi hyperimmunized syngenic receivers with transplanted organs, which lasted for months. The histological study of transplanted cardiac tissue in Chagas' mice revealed intense and persistent mononuclear inflammatory infiltrate, similar to that obtained under allogenic conditions, thus indicating the implication of cellular mechanisms.
A series of tests was carried out to determine the phenotype of those cells involved in syngenical heart rejection phenomena (Figure 1 ). T CD4 cell depletion in vivo, but not CD8 cells caused cell rejection to be halted, i.e. cardiac transplants survived in chronically infected mice treated with anti CD4 monoclonal antibody (32). Anti C24 monoclonal antibodies have been used successfully in similar experiments to show the tolerance induction in Langerhaus islets allotransplantation in mice, or allogenic heart transplants in rats (44, 45) . In vivo studies with T CD4 lymphocyte from chronically infected mice by T. cruzi have shown that, injected in situ, it brings about the destruction of syngenic transplants of normal mice hearts (32). On the other hand, T CD8 cells or non T cells were ineffective. These results, when analyzed collectively, demonstrated that self reactivity is restricted to T CD4 cell division, in contrast to skin allogenic transplant rejection attributed to the T CD4 and CD8 lymphocytes (6, 19) It is known that the expression CD4 correlates with the cell's capacity to recognize antigens connected with class II molecules (12,47). As no formal demonstration exists that myocytes can express class II molecules in the membrane, it seems unlikely that T CD4 cells are responsible for the final cytotoxic effector" activity. We have recently related that the red ruthenium strongly marks the myocytes' cytoplasmic components at the point of contact, or in close approximation of the macrophages, indicating altered areas of the plasmatic membrane with an increase in permeability.
These observations suggest that the mononuclear cell with the appearance of activated macrophage would be the effector cell which injures the myocytes.
In this case T CD4 lymphocytes would recognize the myocardial antigens together with the class II antigens expressed in resident macrophages or dendritic cells, activating the T CD4 cells, with a subsequent production of interleucin (46). Thus an inflammatory process would begin, inducing the destruction of the myocardial tissue.
An interesting question brought up from this data refers to self reacting T CD4 lymphocyte activation. The molecular mimetism between myocardium antigens and T. cruzi may be ultimately responsible (50).
However, T. crud hyperimmunized mice do not reject syngenical heart transplants. Apart from this the CD4 cells of these mice, injected in situ, do not destroy the implants and do not proliferate in vitro in the presence of heart antigens (32). Acute infection and large lesions of the target organ would be necessary to cause the rupture of the tissues' specific tolerance. As an example, during the acute phase of the disease T. cruz antigens would copy the myocardial cells and increase the tissue lesion induced by the immune response to the parasite (31). The policing activation of the T and B cells would play an important part during the T. crud infection's acute phase having an important role in the development a posteriori of the disease's self immunity. To date, we support the theory that extensive tissue lesions and self immune dysfunction during the acute phase, more than crossed reacti vi ty between its own and T. cruzi antigens, would be absolutely essential for organ-specific self-immunity in the chronic phase to appear. Chronically T. cruzi infected isogenic mice show T CD4 lymphocytes responsive to myosin (33). The liberated myosin due to cellular lesion would be processed and shown by resident macrophages or by cells dendritic to the T CD4 cells which modulate antibody production, and by inducing macrophage activation and subsequent tissue lesion. Apart from this, evidence suggests that the T-cells playa part in the fibrosis pathogenesis, acting directly on the fibroblasts, by drawing up cytocins, or indirectly by amplifying macrophage activity (21).
These findings allow us to conclude that self immunity is the principle mechanism implied in the rejection of transplanted syngenic cardiac tissue in the ear of chronically T. cruzi infected mice. The similarity of the lesions to those observed in humans suggests that self immunity is involved in human Chagas' myocarditis pathogenesis. This may imply therapeutic strategies for re-establishing the chronic specific tolerance by treatment with anti-CD4 mononuclear antibodies, mediating energy or the suppression of responsive T CD4 cells.
Within this context, an important aspect to be taken into consideration is that related to those factors which contribute to the progression from the acute phase to the intermediate phase of Chagas' disease and to those factors involved in the progression from the intermediate phase to the disease's chronic phase. It has been proposed that regions of focal myocytolic necrosis, interstitial fibrosis and hypertrophy of the circumjacent cardiac muscle cells. Apart from this, the hypothesis has been put forward that the inflammatory infiltrate consisting predominantly of macrophages and lymphocytes contributes to the state of microvascular hypoperfusion of the secretion of A2 thromboxan and platelet aggregation and vessel spasm.
Microvascular spasm and microaneurism formation in coronary circulation were described in acute T. cruzi infection in mice (8) in a similar manner to that observed in other congestive myocardiopathy (9,11). These microvascular changes were detected early on during the evolution of experimental Chagas' disease, before the onset of degeneration or myocardial fibrosis.
To back up the microvascular hypothesis it has been related that chronic administration of Verapamil, a calciumchannel blocking drug, produced a significant reduction in inflammation and myocardial fibrosis in T. cruzi infected mice, apart from a 10 times lower mortality rate during a 70-day observation period (27). Verapamil apparently maintains vascular perfusion by vasodilation as a consequence of its action on the smooth muscle cells and by an inhibiting effect on platelet aggregation (4). In vitro studies have shown infection related endothelial cell dysfunction and a subsequent increase in platelet reactivity (48). Interaction between platelets and damaged endothelium or the subendothelial surface may stimulate platelet derived growth factor. The finding of high levels of A2 thromboxan in acutely infected plasma would contribute to platelet aggregation increasing the focal microvascular spasm.
Recent scintillographic studies using Thallium-20 1 in chronic dilated cardiopathic Chagas' patients have demonstrated a decrease in myocardial perfusion (14,23), a likely consequence of microvascular ischemia (29). Within this context myocardial perfusion decrease has been described in 15 to 30 day post T. cruzi infected mice, radiographically evaluated using the 19-Iodine-3.3-dimethyl-18 nonadecenoic fatty acid (49).
THEORY
In this present work we have presented an alternati ve hypothesis concerning chronic Chagas' myocarditis pathogenesis development is related to progressive and accumulative focal cellular necrosis, associated with distributive and reactive interstitial fibrosis and circumjacent myocytic hypertrophy. These processes are initiated and perpetuated by self immune factors and by alterations to myocardial microcirculation (Fig. 2) . The autonomous nervous system's intrinsic alterations are implicated in the global context of the clinical-pathological evolution of chronic Chagas' cardiopathy. The proposed physiopathogenic mechanism would imply future therapeutic strategy for treating chronic Chagas' patients, enhancing medical care and treatment and, hopefully, improving prognosis. 
